Medpace Holdings, Inc. (MEDP)

Market Cap	9.37B
Revenue (ttm)	2.16B
Net Income (ttm)	416.39M
Shares Out	28.74M
EPS (ttm)	13.09
PE Ratio	24.91
Forward PE	26.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	378,931
Open	319.40
Previous Close	321.07
Day's Range	318.03 - 328.06
52-Week Range	250.05 - 459.77
Beta	1.47
Analysts	Hold
Price Target	338.90 (+3.95%)
Earnings Date	Jul 21, 2025

About MEDP

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigi...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 11, 2016
• Employees: 5,900
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDP
• Website: https://www.medpace.com

Financial Performance

In 2024, Medpace Holdings's revenue was $2.11 billion, an increase of 11.84% compared to the previous year's $1.89 billion. Earnings were $404.34 million, an increase of 43.07%.

Analyst Summary

According to 11 analysts, the average rating for MEDP stock is "Hold." The 12-month stock price target is $338.9, which is an increase of 3.95% from the latest price.

Price Target

$338.9

(3.95% upside)

Analyst Consensus: Hold